The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients

Race/Ethnic Difference in Diabetes and Diabetic Complications

(2013) Elias K. Spanakis et al.   Current Diabetes Reports

What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus?

(2013) L. Zenari et al.   DIABETES OBESITY & METABOLISM

The Effect of Pioglitazone and Metformin on Liver Function Tests, Insulin Resistance, and Liver Fat Content in Nonalcoholic Fatty Liver Disease: A Randomized Double Blinded Clinical Trial

(2013) Mohsen Razavizade et al.   Hepatitis Monthly

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

(2013) Young Ki Lee et al.   Diabetes & Metabolism Journal

Health Disparities in Endocrine Disorders: Biological, Clinical, and Nonclinical Factors—An Endocrine Society Scientific Statement

(2012) Sherita Hill Golden et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

PIOfix-Study: Effects of Pioglitazone/Metformin Fixed Combination in Comparison with a Combination of Metformin with Glimepiride on Diabetic Dyslipidemia

(2011) Andreas Pfützner et al.   Diabetes Technology & Therapeutics

Effects of Pioglitazone Add-On to Gliclazide and Metformin on Glycemic Control in Patients with Type 2 Diabetes

(2011) Sayer I. Al-Azzam et al.   ENDOCRINE RESEARCH

The Effects of Pioglitazone in Reducing Atherosclerosis Progression and Neointima Volume in Type 2 Diabetic Patients: Prospective Randomized Study With Volumetric Intravascular Ultrasonography Analysis

(2011) Sung Hye You et al.   Korean Circulation Journal

Efficacy and Tolerability of Pioglitazone in Patients with Type 2 Diabetes Mellitus

(2010) Giuseppe Derosa   DRUGS

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE